companydata.dkShire Biotech Denmark ApS: Financial statements 2017
CVR: 33358008
Shire Biotech Denmark ApS (CVR 33358008) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 12,675,556 and a net result of DKK 860,343 compared with DKK 775,583 the year before. That is an increase of 39% compared with the year before. Equity amounted to DKK 3,207,794. The solvency ratio was 32.4%. The company had 9 employees in the financial year.
- Gross Profit
- 12,675,556 kr.
- Profit/Loss
- 860,343 kr.
- Equity
- 3,207,794 kr.
- Total Assets
- 9,912,572 kr.
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 12.7 mio. | 860 t. | 3.2 mio. | 9 |
| 2016 | - | 9.1 mio. | 776 t. | 2.3 mio. | - |
| 2015 | - | 9.7 mio. | 669 t. | 1.6 mio. | - |
| 2014 | - | 7.2 mio. | 343 t. | 903 t. | - |
| 2013 | - | 4.8 mio. | 232 t. | 561 t. | - |
Find more companies like Shire Biotech Denmark ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
Shire Biotech Denmark ApS has published its annual report for 2016. Gross profit came to DKK 9,116,935, and the net result was DKK 775,583.
As of May 29, 2017, Kerstin Anna-Lena Engvall is registered as adm. dir. of Shire Biotech Denmark ApS.
As of May 29, 2017, Paul Michael Blanchfield has stepped down as director of Shire Biotech Denmark ApS.
As of April 21, 2017, Jacob Fredrik Westin has joined the board of directors of Shire Biotech Denmark ApS.
As of April 21, 2017, Johan Åke Östen Pettersson has joined the board of directors of Shire Biotech Denmark ApS.
As of April 21, 2017, Helen Alice Lillistone has left the board of directors of Shire Biotech Denmark ApS.
As of April 21, 2017, Paul Michael Blanchfield has left the board of directors of Shire Biotech Denmark ApS.
As of April 21, 2017, Amanda Miller has left the board of directors of Shire Biotech Denmark ApS.
As of April 21, 2017, Kerstin Anna-Lena Engvall is registered as chairman of Shire Biotech Denmark ApS.
About Shire Biotech Denmark ApS
Shire Biotech Denmark ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2010 and dissolved in 2018. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 0 employees. In 2017, the company reported a gross profit of DKK 12,675,556 and a net result of DKK 860,343 compared with DKK 775,583 the year before. Equity amounted to DKK 3,207,794.